Literature DB >> 25896896

Special Commentary: Food and Drug Administration and American Academy of Ophthalmology Sponsored: Developing Novel End Points for Premium Intraocular Lenses Workshop.

Flora Lum1, Michelle E Tarver2, Malik Y Kahook3, Thomas A Oetting4, Eva Rorer2, Gene Hilmantel2, Don Calogero2, Tina Kiang2, John P Berdahl5, Anne L Coleman6, Malvina B Eydelman7.   

Abstract

Mesh：

Year:  2015        PMID： 25896896     DOI： 10.1016/j.ophtha.2015.02.038

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  Patient-reported outcome measures in inherited retinal degeneration gene therapy trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; David C Musch; Kanishka T Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-02-26       Impact factor: 1.803

2.  Monocular Clinical Outcomes and Range of Near Vision following Cataract Surgery with Implantation of an Extended Depth of Focus Intraocular Lens.

Authors:  Rahul T Pandit
Journal:  J Ophthalmol       Date:  2018-12-13       Impact factor: 1.909
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.